DR. GEVERS
ActiveSummary
DR. GEVERS has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €437,102 and a net result of €89,137. Equity is growing by ~25.8% per year across the filed fiscal years. Its solvency ranks better than 40% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability82▼-4
Solvency76▼-18
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 2.5 against 6.49 in 2024; short-term debt: 31% and cash: 15.5% of total assets), and 48.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
51.4%
Return on assets
10.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
36 d early
2024
41 d early
2023
26 d early
2022
40 d early
2021
24 d late
2020
121 d late
2019
87 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 13 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 25 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€437,102▼ 22.6%
2024 · €564,777
Total assets
€850,556▲ 3.2%
2024 · €823,952
Net result
€89,137▼ 23.5%
2024 · €116,573
Working capital
€396,545▼ 17.9%
2024 · €483,148
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€102,431▲ 60.3%€120,952▲ 18.1%€162,608▲ 34.4%€164,133▲ 0.9%€128,684▼ 21.6%
Net result€60,867within the sector's middle half▲ 15.3%€80,304within the sector's middle half▲ 31.9%€112,216above the sector's middle half▲ 39.7%€116,573within the sector's middle half▲ 3.9%€89,137within the sector's middle half▼ 23.5%
Equity€303,338within the sector's middle half▲ 25.1%€382,380above the sector's middle half▲ 26.1%€494,596above the sector's middle half▲ 29.3%€564,777above the sector's middle half▲ 14.2%€437,102above the sector's middle half▼ 22.6%
Total assets€423,355within the sector's middle half▲ 35.4%€508,846within the sector's middle half▲ 20.2%€617,965above the sector's middle half▲ 21.4%€823,952above the sector's middle half▲ 33.3%€850,556above the sector's middle half▲ 3.2%
Debt€120,017▲ 71.1%€126,466▲ 5.4%€123,369▼ 2.4%€259,175▲ 110%€413,454▲ 59.5%
Working capital€204,506within the sector's middle half▲ 59.5%€309,740above the sector's middle half▲ 51.5%€389,067above the sector's middle half▲ 25.6%€483,148above the sector's middle half▲ 24.2%€396,545above the sector's middle half▼ 17.9%
Solvency71.7%within the sector's middle half▼ 5.9pp75.1%within the sector's middle half▲ 3.5pp80.0%within the sector's middle half▲ 4.9pp68.5%within the sector's middle half▼ 11.5pp51.4%within the sector's middle half▼ 17.2pp
Current ratio2.76within the sector's middle half▼ 0.223.54within the sector's middle half▲ 0.7710.19above the sector's middle half▲ 6.666.49within the sector's middle half▼ 3.702.50within the sector's middle half▼ 3.99
Return on assets (ROA)14.4%within the sector's middle half▼ 2.5pp15.8%within the sector's middle half▲ 1.4pp18.2%within the sector's middle half▲ 2.4pp14.1%within the sector's middle half▼ 4.0pp10.5%within the sector's middle half▼ 3.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 22% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €850,556
Fixed assets
€190,277 ▼ 24.8%
Current assets
€660,279 ▲ 15.6%
Equity and liabilities €850,556
Equity
€437,102 ▼ 22.6%
Debt
€413,454 ▲ 59.5%
Debt's share of the balance-sheet total rises from 31.5% to 48.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€178,376▼
2024 · €208,808
Cash flow
€138,830▼
2024 · €161,249
Debt to equity
0.95▲
2024 · 0.46
ROE
20.4%▼
2024 · 20.6%
Interest coverage
13.75▼
2024 · 29.97
Debt ≤ 1 year
€263,735▲
2024 · €87,927
Debt > 1 year
€137,654▼
2024 · €168,929
Income taxes
€39,584▼
2024 · €46,106
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,129 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,129 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €990 | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €35,481 | €31,805 | €13,045 | €44,675 | €49,693 | ▲ 11.2% |
| Other operating charges640/8 | €3,758 | €2,162 | €3,699 | €2,522 | €1,429 | ▼ 43.3% |
| Non-recurring operating charges66A | - | - | - | €1,447 | €0 | ▼ 100% |
| Gross operating margin9900 | €141,669 | €154,919 | €179,352 | €212,777 | €179,806 | ▼ 15.5% |
| Operating profit (loss)9901 | €102,431 | €120,952 | €162,608 | €164,133 | €128,684 | ▼ 21.6% |
| Financial income75/76B | €44 | €646 | €6,245 | €5,515 | €13,015 | ▲ 136% |
| Recurring financial income75 | €44 | €646 | €1,686 | €5,515 | €13,015 | ▲ 136% |
| Non-recurring financial income76B | - | - | €4,560 | €0 | - | - |
| Financial charges65/66B | €2,687 | €4,314 | €1,014 | €6,967 | €12,977 | ▲ 86.3% |
| Recurring financial charges65 | €2,687 | €4,314 | €1,014 | €6,967 | €12,977 | ▲ 86.3% |
| Profit (loss) for the period before taxes9903 | €99,787 | €117,284 | €167,839 | €162,680 | €128,721 | ▼ 20.9% |
| Income taxes67/77 | €38,921 | €36,980 | €55,622 | €46,106 | €39,584 | ▼ 14.1% |
| Profit (loss) for the period9904 | €60,867 | €80,304 | €112,216 | €116,573 | €89,137 | ▼ 23.5% |
| Transfer from tax-exempt reserves789 | €26,927 | - | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €87,794 | €80,304 | €112,216 | €116,573 | €89,137 | ▼ 23.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €423,355 | €508,846 | €617,965 | €823,952 | €850,556 | ▲ 3.2% |
| Fixed assets21/28 | €102,864 | €76,928 | €186,573 | €252,877 | €190,277 | ▼ 24.8% |
| Tangible fixed assets22/27 | €102,864 | €76,928 | €186,573 | €252,877 | €190,277 | ▼ 24.8% |
| Land and buildings22 | €9,150 | €10,657 | €7,558 | €96,301 | €58,280 | ▼ 39.5% |
| Plant, machinery and equipment23 | €16,087 | €12,331 | €25,869 | €34,901 | €27,403 | ▼ 21.5% |
| Furniture and vehicles24 | €77,626 | €53,941 | €153,147 | €121,675 | €104,594 | ▼ 14.0% |
| Current assets29/58 | €320,491 | €431,918 | €431,391 | €571,075 | €660,279 | ▲ 15.6% |
| Amounts receivable within one year40/41 | - | €681 | €19,645 | €31,135 | €204,548 | ▲ 557% |
| Trade receivables40 | - | €681 | €15,110 | €4,633 | €4,905 | ▲ 5.9% |
| Other amounts receivable41 | - | - | €4,536 | €26,502 | €199,643 | ▲ 653% |
| Current investments50/53 | €122,762 | €161,831 | €175,163 | €375,163 | €319,363 | ▼ 14.9% |
| Cash at bank and in hand54/58 | €191,433 | €260,645 | €232,551 | €154,709 | €131,824 | ▼ 14.8% |
| Deferred charges and accrued income490/1 | €6,296 | €8,761 | €4,032 | €10,068 | €4,544 | ▼ 54.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €423,355 | €508,846 | €617,965 | €823,952 | €850,556 | ▲ 3.2% |
| Equity10/15 | €303,338 | €382,380 | €494,596 | €564,777 | €437,102 | ▼ 22.6% |
| Contributions10/11 | €20,000 | €20,000 | €20,000 | €20,000 | €20,000 | = |
| Reserves13 | €281,947 | €355,276 | €467,492 | €537,673 | €409,998 | ▼ 23.7% |
| Non-distributable reserves130/1 | €2,000 | €2,000 | €0 | - | - | - |
| Reserves not available under the articles1311 | €2,000 | €2,000 | €0 | - | - | - |
| Tax-exempt reserves132 | €5,795 | €5,795 | €5,795 | €5,795 | €5,795 | = |
| Distributable reserves133 | €274,152 | €347,481 | €461,697 | €531,879 | €404,204 | ▼ 24.0% |
| Profit (loss) carried forward14 | €1,391 | €7,104 | €7,104 | €7,104 | €7,104 | = |
| Amounts payable17/49 | €120,017 | €126,466 | €123,369 | €259,175 | €413,454 | ▲ 59.5% |
| Amounts payable after more than one year17 | €990 | €1,050 | €81,045 | €168,929 | €137,654 | ▼ 18.5% |
| Financial debts170/4 | - | - | €79,995 | €167,879 | €136,604 | ▼ 18.6% |
| Other amounts payable178/9 | €990 | €1,050 | €1,050 | €1,050 | €1,050 | = |
| Amounts payable within one year42/48 | €115,985 | €122,178 | €42,324 | €87,927 | €263,735 | ▲ 200% |
| Current portion of amounts payable after more than one year42 | €1,250 | - | €18,497 | €30,097 | €31,275 | ▲ 3.9% |
| Trade debts44 | - | - | - | - | €16,686 | - |
| Suppliers440/4 | - | - | - | - | €16,686 | - |
| Taxes, remuneration and social security45 | €43,673 | €36,028 | €21,929 | €13,757 | €11,014 | ▼ 19.9% |
| Taxes450/3 | €43,673 | €36,028 | €21,929 | €13,757 | €11,014 | ▼ 19.9% |
| Other amounts payable47/48 | €71,062 | €86,150 | €1,897 | €44,072 | €204,760 | ▲ 365% |
| Accrued charges and deferred income492/3 | €3,042 | €3,238 | €0 | €2,320 | €12,065 | ▲ 420% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €60,867 | €80,304 | €112,216 | €116,573 | €89,137 | ▼ 23.5% |
| + Depreciation and write-downs630 | €35,481 | €31,805 | €13,045 | €44,675 | €49,693 | ▲ 11.2% |
| Operating cash flow (approximation) | €96,347 | €112,109 | €125,262 | €161,249 | €138,830 | ▼ 13.9% |
| Investment in fixed assets (approximation) | - | -€5,869 | -€122,691 | -€110,979 | €12,908 | ▲ 112% |
| Change in cash | - | €69,212 | -€28,094 | -€77,842 | -€22,885 | ▲ 70.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
25-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
20-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €116,573 ▲3.9%
Operating result €164,133, net result €116,573, both a record.
31-12
Financial
Equity above €500,000Eq €564,777 ▲14.2%
7 profitable years in a row build equity to €564,777.
05-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity triplescurrent ratio 10.19
Current ratio from 3.54 to 10.19; short-term debt falls from €122,178 to €42,324.
21-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
24-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 24 days late
2021
29-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 121 days late
2020
31-12
Financial
Equity above €200,000Eq €242,471 ▲27.8%
3 profitable years in a row build equity to €242,471.
26-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 87 days late
2019
31-12
Financial
Equity above €150,000Eq €189,669 ▲51%
2 profitable years in a row build equity to €189,669.
Show earlier events
11-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 72 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
31-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2003
Ground area
224 m²
Building footprint
83 m²
Volume, LiDAR
941 m³
Parcel 71022H1368/00K000, Flanders · tallest building 14.6 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Thonissenlaan 59, 3500 Hasselt
since 20032.190.623.155
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71022H1368/00K000 | Flanders | 224 m² | 1 · 83 m² | 14.6 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DERMATEN
BE 0463.416.906
Nivelles · Eq €437,121
DR.EVA BEQUÉ - huisarts
BE 0832.261.582
Merelbeke-Melle · Eq €437,203
Verbeke-Kransfeld
BE 0647.522.213
Mol · Eq €436,805
RADIONC REMOUCHAMPS
BE 0822.162.201
Floreffe · Eq €437,440
Dr. Carl Tack
BE 0568.830.269
Pittem · Eq €437,524
Of 9,128 companies in sector 86210 we hold annual accounts for 6,335. 5,000 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded10-07-2003
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
96302Personal service activities
E-invoicing
Reachable via Peppol
Peppol ID
0208:0859634388
Also
9925:BE0859634388
Registered
22-12-2024
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.